FDA Drug Update
Posted: Dec 15 2016
Each month the FDA approves new medications, and below is a highlight of the most relevant new approvals and/or drugs which have the potential to impact your prescription plan. While the medications below have been evaluated and approved by the FDA, they may not enter the marketplace for several weeks or months. Therefore, pricing information for these medications is typically unavailable at the time of approval.

New Brand Approvals
Drug NameUses/TreatmentPricing InformationOther Information
Bonjesta® (doxylamine/pyridoxine)Treatment of nausea and vomiting of pregnancy in women who do not respond to conservative managementPricing information not yet available• Drug Information: Bonjesta is a fixed dose combination of an antihistamine and Vitamin B6 analog, for the treatment of nausea and vomiting of pregnancy
• Formulary Management: Considered non-preferred upon market entry. 
• Control Trak: Subject to Max Dollar and Max Dose edits.
Xultophy® (insulin degludec/liraglutide)Treatment of type 2 diabetesPricing information not yet available• Drug Information: Xultophy is a combination of a long-acting insulin analog and a glucagon-like peptide 1 receptor agonist, indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes inadequately controlled on basal insulin or liraglutide
• Formulary Management: Considered non-preferred upon market entry. 
• Control Trak: Subject to Max Dollar and Max Dose edits.
Soliqua® (insulin glargine/lixisenatide)Treatment of type 2 diabetesPricing information not yet available• Drug Information: Soliqua is a combination of a long-acting insulin analog and a glucagon-like peptide 1 receptor agonist, indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes inadequately controlled on basal insulin or lixisenatide
• Formulary Management: Considered non-preferred upon market entry. 
• Control Trak: Subject to Max Dollar and Max Dose edits.


New Generic Approvals
Drug NameUses/TreatmentPricing InformationOther Information
Quetiapine Extended-Release TabletsSchizophrenia, bipolar disorder, or major depressive disorderPricing information not yet available • Drug Information: Quetiapine extended-release is generic for Seroquel XR. Generic formulations of regular release Seroquel have been on the market for several years and have been widely used. 
• Control Trak: Subject to Max Dollar and Max Dose edits.


The Clinical Care Center (CCC) is MedTrak’s comprehensive clinical solution to control costs and increase adherence for our Clients and Members. The Clinical Care Center is made up of 7 Steps to Improved Outcomes: Generics Plus, Formulary Management, Member & Client Education, RightChoice, Control Trak, Best-In-Class (BIC) SpecialtyRx, and Clinical Concierge.